SCHEMBL10119504

SCHEMBL10119504

CCC(=O)c1ccccc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3OCc3ccccc3C(C)=O)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
PABPC1 P11940 1/20 0.41
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPC1 O15118 1/20 0.39
MAPK1 P28482 2/20 0.39
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 3/20 0.39
HTT P42858 1/20 0.39
MAPT P10636 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
EP300 Q09472 1/20 0.37
CREBBP Q92793 1/20 0.37
TSHR P16473 1/20 0.36
KDM1A O60341 1/20 0.36
RCOR1 Q9UKL0 1/20 0.36
CFD P00746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845929 0.88 GAA (0.48) GAALMNAKDM4EPABPC1CYP2C9
SCHEMBL845285 0.87 GAA (0.48) GAALMNAKDM4EPABPC1CYP2C9
SCHEMBL10119511 0.82 GAA (0.44) GAALMNAKDM4EPABPC1CYP2C9
SCHEMBL844996 0.82 CYP2C9 (0.50) GAALMNAPABPC1CYP2C9CYP2C19
SCHEMBL871645 0.81 PABPC1 (0.43) GAALMNAKDM4EPABPC1CYP2C9
SCHEMBL873858 0.81 GAA (0.42) GAALMNAKDM4EPABPC1CYP2C9
SCHEMBL845131 0.80 PABPC1 (0.49) GAALMNAKDM4EPABPC1CYP2C9
SCHEMBL845007 0.80 PABPC1 (0.49) GAALMNAKDM4EPABPC1CYP2C9
SCHEMBL845008 0.75 ALDH1A1 (0.54) LMNACYP2C9CYP2C19MAPK1ALDH1A1
SCHEMBL845312 0.75 GAA (0.60) GAALMNAKDM4EPABPC1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed